Literature DB >> 16221546

Dietary eicosapentaenoic acid modulates CTLA-4 expression in murine CD4+ T-cells.

Lan H Ly1, Roger Smith, Kirsten C Switzer, Robert S Chapkin, David N McMurray.   

Abstract

We have demonstrated that downregulation of proliferation by CD4(+) T-cells in mice fed n-3 PUFA diets is dependent on the involvement of CD28. Therefore, we hypothesized that the balance of co-stimulatory and downregulatory properties of CD28 and CTLA-4, respectively, would be altered by diet. Mice were fed a control corn oil (CO)-enriched diet devoid of n-3 PUFA, or diets enriched with either docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) for 14d. The proliferation of splenic CD4(+) T-cells was suppressed by DHA and EPA following stimulation with anti-CD3 and anti-CD28. Surprisingly, the number of surface CD28 molecules was not reduced in activated CD4(+) T-cells from either group of n-3 PUFA-fed mice. However, in mice fed EPA, CTLA-4 protein levels were enhanced significantly 72 h post-activation (P<0.01). Therefore, we conclude that dietary EPA may suppress CD4(+) T-cell activation by enhancing the downregulatory co-receptor CTLA-4, while not altering the levels of CD28.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221546     DOI: 10.1016/j.plefa.2005.09.001

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  11 in total

Review 1.  Regulatory activity of polyunsaturated fatty acids in T-cell signaling.

Authors:  Wooki Kim; Naim A Khan; David N McMurray; Ian A Prior; Naisyin Wang; Robert S Chapkin
Journal:  Prog Lipid Res       Date:  2010-02-20       Impact factor: 16.195

2.  Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells.

Authors:  Akadiri Yessoufou; Aude Plé; Kabirou Moutairou; Aziz Hichami; Naim Akhtar Khan
Journal:  J Lipid Res       Date:  2009-06-27       Impact factor: 5.922

Review 3.  Omega-3 fatty acids, lipid rafts, and T cell signaling.

Authors:  Tim Y Hou; David N McMurray; Robert S Chapkin
Journal:  Eur J Pharmacol       Date:  2015-05-20       Impact factor: 4.432

4.  CD4(+) T-cell activation is differentially modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated fatty acids.

Authors:  Susanne Brix; Pia Lund; Tanja M R Kjaer; Ellen M Straarup; Lars I Hellgren; Hanne Frøkiaer
Journal:  Immunology       Date:  2009-11-11       Impact factor: 7.397

5.  Dietary perilla oil inhibits proinflammatory cytokine production in the bronchoalveolar lavage fluid of ovalbumin-challenged mice.

Authors:  Hui-Hsiang Chang; Chin-Shun Chen; Jin-Yuarn Lin
Journal:  Lipids       Date:  2008-04-02       Impact factor: 1.880

Review 6.  Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation.

Authors:  Robert S Chapkin; Wooki Kim; Joanne R Lupton; David N McMurray
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-06-06       Impact factor: 4.006

7.  fat-1 transgene expression prevents cell culture-induced loss of membrane n-3 fatty acids in activated CD4+ T-cells.

Authors:  Yang-Yi Fan; Wooki Kim; Evelyn Callaway; Roger Smith; Qian Jia; Lan Zhou; David N McMurray; Robert S Chapkin
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-10-31       Impact factor: 4.006

Review 8.  Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction.

Authors:  Danyelle M Liddle; Amber L Hutchinson; Hannah R Wellings; Krista A Power; Lindsay E Robinson; Jennifer M Monk
Journal:  Nutrients       Date:  2017-11-27       Impact factor: 5.717

Review 9.  Effects of fatty acids on T cell function: role in atherosclerosis.

Authors:  Nathalie A Reilly; Esther Lutgens; Johan Kuiper; Bastiaan T Heijmans; J Wouter Jukema
Journal:  Nat Rev Cardiol       Date:  2021-07-12       Impact factor: 32.419

Review 10.  The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease.

Authors:  Chunxiang Ma; Reshma Vasu; Hu Zhang
Journal:  Mediators Inflamm       Date:  2019-11-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.